<DOC>
	<DOCNO>NCT00504816</DOCNO>
	<brief_summary>The purpose research study demonstrate lack effect multiple dose GSK189075 PK oral contraceptive pill healthy female subject . To estimate effect GSK189075 hormonal level birth control .</brief_summary>
	<brief_title>A Study Effects GSK189075 PK Profiles Oral Contraceptive Pill When Given Healthy Female Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Norethindrone acetate , ethinyl estradiol , ferrous fumarate drug combination</mesh_term>
	<mesh_term>Norinyl</mesh_term>
	<mesh_term>Norethindrone</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Contraceptives , Oral , Combined</mesh_term>
	<mesh_term>Mestranol</mesh_term>
	<criteria>healthy , nonsmoking menstruate female age 18 45 year old , inclusive . able take specific oral contraceptive &amp; KG2107494 . female unable child , still ovaries uterus , negative pregnancy test . female child regular period willing use oral contraceptive pill and/or sterile partner . pregnant nursing female . female subject able child unwilling unable use appropriate method birth control least 2 week prior first dose study drug completion Followup visit . Have suffer certain infection within 4 week prior first dose study drug</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>healthy female ,</keyword>
	<keyword>pharmacokinetics ,</keyword>
	<keyword>pharmacodynamics</keyword>
	<keyword>drug interaction ,</keyword>
</DOC>